Chronic lithium administration alters behavioral recovery from nigrostriatal injury: Effects on neostriatal [3H]spiroperidol binding sites

Michael R. Kozlowski, Kim Neve, Jonathan E. Grisham, John F. Marshall

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Unilateral damage to the mesotelencephalic dopaminergic projection of the rat produces impairments in sensorimotor functions, including an inability to localize contralateral somatosensory stimuli. Many rats with 6 hydroxydopamine injections along this pathway show a gradual improvement in somatosensory localization during the first post-operative month. One mechanism that may contribute to this behavioral recovery is the proliferation of dopamine receptor sites in the affected neostriatum. The role of these binding site changes in the recovery was tested by chronic administration of lithium to rats. Rats given lithium in their drinking water for 4 weeks after the 6-hydroxydopamine injection showed a greatly attenuated recovery of sensorimotor functions, compared to brain-damaged rats drinking unadulterated water. When rats that were given lithium for the first postoperative weeks were subsequently given unadulterated water top drink, they recovered normally. Lithium treatment did not prevent the augmentation of [3H]spiroperidol binding in the neostriatum ipsilateral to the lesion, relative to the contralateral control neostriatum, at 4 or 8 weeks post-operatively. Thus, lithium treatment dissociates behavioral recovery after nigrostriatal injury from the lesion-induced relative proliferation of neostriatal [3H]spiroperidol binding sites. However, the lithium treatment decreased the absolute amount of specific [3H]spiroperidol binding to both the ipsilateral and contralateral neostriata. The significance of these findings for the neural mechanism underlying this recovery sequence is discussed.

Original languageEnglish (US)
Pages (from-to)301-311
Number of pages11
JournalBrain Research
Volume267
Issue number2
DOIs
StatePublished - May 16 1983
Externally publishedYes

Fingerprint

Spiperone
Lithium
Neostriatum
Binding Sites
Wounds and Injuries
Oxidopamine
Drinking Water
Injections
Recovery of Function
Dopamine Receptors
Therapeutics
Water
Brain

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Chronic lithium administration alters behavioral recovery from nigrostriatal injury : Effects on neostriatal [3H]spiroperidol binding sites. / Kozlowski, Michael R.; Neve, Kim; Grisham, Jonathan E.; Marshall, John F.

In: Brain Research, Vol. 267, No. 2, 16.05.1983, p. 301-311.

Research output: Contribution to journalArticle

Kozlowski, Michael R. ; Neve, Kim ; Grisham, Jonathan E. ; Marshall, John F. / Chronic lithium administration alters behavioral recovery from nigrostriatal injury : Effects on neostriatal [3H]spiroperidol binding sites. In: Brain Research. 1983 ; Vol. 267, No. 2. pp. 301-311.
@article{910321a208084d8db4b3fdaffed99b00,
title = "Chronic lithium administration alters behavioral recovery from nigrostriatal injury: Effects on neostriatal [3H]spiroperidol binding sites",
abstract = "Unilateral damage to the mesotelencephalic dopaminergic projection of the rat produces impairments in sensorimotor functions, including an inability to localize contralateral somatosensory stimuli. Many rats with 6 hydroxydopamine injections along this pathway show a gradual improvement in somatosensory localization during the first post-operative month. One mechanism that may contribute to this behavioral recovery is the proliferation of dopamine receptor sites in the affected neostriatum. The role of these binding site changes in the recovery was tested by chronic administration of lithium to rats. Rats given lithium in their drinking water for 4 weeks after the 6-hydroxydopamine injection showed a greatly attenuated recovery of sensorimotor functions, compared to brain-damaged rats drinking unadulterated water. When rats that were given lithium for the first postoperative weeks were subsequently given unadulterated water top drink, they recovered normally. Lithium treatment did not prevent the augmentation of [3H]spiroperidol binding in the neostriatum ipsilateral to the lesion, relative to the contralateral control neostriatum, at 4 or 8 weeks post-operatively. Thus, lithium treatment dissociates behavioral recovery after nigrostriatal injury from the lesion-induced relative proliferation of neostriatal [3H]spiroperidol binding sites. However, the lithium treatment decreased the absolute amount of specific [3H]spiroperidol binding to both the ipsilateral and contralateral neostriata. The significance of these findings for the neural mechanism underlying this recovery sequence is discussed.",
author = "Kozlowski, {Michael R.} and Kim Neve and Grisham, {Jonathan E.} and Marshall, {John F.}",
year = "1983",
month = "5",
day = "16",
doi = "10.1016/0006-8993(83)90882-X",
language = "English (US)",
volume = "267",
pages = "301--311",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Chronic lithium administration alters behavioral recovery from nigrostriatal injury

T2 - Effects on neostriatal [3H]spiroperidol binding sites

AU - Kozlowski, Michael R.

AU - Neve, Kim

AU - Grisham, Jonathan E.

AU - Marshall, John F.

PY - 1983/5/16

Y1 - 1983/5/16

N2 - Unilateral damage to the mesotelencephalic dopaminergic projection of the rat produces impairments in sensorimotor functions, including an inability to localize contralateral somatosensory stimuli. Many rats with 6 hydroxydopamine injections along this pathway show a gradual improvement in somatosensory localization during the first post-operative month. One mechanism that may contribute to this behavioral recovery is the proliferation of dopamine receptor sites in the affected neostriatum. The role of these binding site changes in the recovery was tested by chronic administration of lithium to rats. Rats given lithium in their drinking water for 4 weeks after the 6-hydroxydopamine injection showed a greatly attenuated recovery of sensorimotor functions, compared to brain-damaged rats drinking unadulterated water. When rats that were given lithium for the first postoperative weeks were subsequently given unadulterated water top drink, they recovered normally. Lithium treatment did not prevent the augmentation of [3H]spiroperidol binding in the neostriatum ipsilateral to the lesion, relative to the contralateral control neostriatum, at 4 or 8 weeks post-operatively. Thus, lithium treatment dissociates behavioral recovery after nigrostriatal injury from the lesion-induced relative proliferation of neostriatal [3H]spiroperidol binding sites. However, the lithium treatment decreased the absolute amount of specific [3H]spiroperidol binding to both the ipsilateral and contralateral neostriata. The significance of these findings for the neural mechanism underlying this recovery sequence is discussed.

AB - Unilateral damage to the mesotelencephalic dopaminergic projection of the rat produces impairments in sensorimotor functions, including an inability to localize contralateral somatosensory stimuli. Many rats with 6 hydroxydopamine injections along this pathway show a gradual improvement in somatosensory localization during the first post-operative month. One mechanism that may contribute to this behavioral recovery is the proliferation of dopamine receptor sites in the affected neostriatum. The role of these binding site changes in the recovery was tested by chronic administration of lithium to rats. Rats given lithium in their drinking water for 4 weeks after the 6-hydroxydopamine injection showed a greatly attenuated recovery of sensorimotor functions, compared to brain-damaged rats drinking unadulterated water. When rats that were given lithium for the first postoperative weeks were subsequently given unadulterated water top drink, they recovered normally. Lithium treatment did not prevent the augmentation of [3H]spiroperidol binding in the neostriatum ipsilateral to the lesion, relative to the contralateral control neostriatum, at 4 or 8 weeks post-operatively. Thus, lithium treatment dissociates behavioral recovery after nigrostriatal injury from the lesion-induced relative proliferation of neostriatal [3H]spiroperidol binding sites. However, the lithium treatment decreased the absolute amount of specific [3H]spiroperidol binding to both the ipsilateral and contralateral neostriata. The significance of these findings for the neural mechanism underlying this recovery sequence is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0020532783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020532783&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(83)90882-X

DO - 10.1016/0006-8993(83)90882-X

M3 - Article

C2 - 6409351

AN - SCOPUS:0020532783

VL - 267

SP - 301

EP - 311

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -